Delivery Order SPE2DB20D3505-SPE2DB22FT3R7
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Trileptal 300 mg/5 ml suspension, a 250 ml medication. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,067.32 and an ultimate completion date of May 23, 2023. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,607.25 Firm Fixed Price Delivery Order is for the supply of Trileptal 300 mg/5 ml suspension in 250 ml bottles. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $3,201.96, is for the delivery of Trileptal 300 mg/5 ml suspension in 250 ml bottles. This is a firm fixed-price delivery order contract with a completion date of May 11, 2023. Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,079.45 firm-fixed-price delivery order is for the supply of TRILEPTAL 300 MG/5 ML SUSP 250ML, a pharmaceutical product. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,540.10 firm fixed-price delivery order is for the supply of Trileptal 300mg/5ml suspension, a medication used to treat epilepsy. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Trileptal 300 mg/5 ml suspension in 250 ml bottles. The award, valued at $5,180.00, is a firm-fixed price contract without any set-aside designation. The period of performance for this delivery order extends through August 2, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- This federal contract award, valued at $2,853.28, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Trileptal 300 mg/5 ml suspension in 250 ml bottles, with a completion date of May 31, 2023. This contract is not designated as a set-aside and is issued as a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,800.81, is for the delivery of Trileptal 300 mg/5 ml suspension in 250 ml bottles. This is a firm fixed-price delivery order contract with a period of performance through May 30, 2024. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant...
- This federal contract award is for the delivery of Trileptal 300 mg/5 ml suspension in 250 ml bottles to the Defense Logistics Agency (DLA). The contract, valued at $2,063.12, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price delivery order, without any set-aside designation, and has an ultimate completion date of January 5, 2022. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,705.59 Firm Fixed Price Delivery Order, with a completion date of March 1, 2023, is for the supply of 4560094860 - TRILEPTAL 300 MG/5 ML SUSP 250ML. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB22FT3R7Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Trileptal 300 mg/5 ml suspension in 250 ml bottles. The $1,486.26 firm fixed-price delivery order was awarded on January 5, 2022, with a completion date of January 6, 2022. The contract has no set-aside designation, indicating it was awarded through full and open competition. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC serves as the primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 1/5/22 |